Barclays Has Lowered Expectations for Sotera Health (NASDAQ:SHC) Stock Price

Sotera Health (NASDAQ:SHC) had its price target decreased by Barclays from $18.00 to $17.00 in a research note released on Tuesday,Benzinga reports. Barclays currently has an overweight rating on the stock.

Several other research firms have also commented on SHC. Citigroup raised their price target on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a report on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective on the stock. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $16.08.

Sotera Health Stock Down 0.8 %

SHC stock opened at $13.52 on Tuesday. The firm has a market cap of $3.83 billion, a PE ratio of 54.08 and a beta of 1.91. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm’s fifty day moving average is $13.45 and its 200 day moving average is $14.56. Sotera Health has a one year low of $10.71 and a one year high of $17.44.

Hedge Funds Weigh In On Sotera Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Blue Trust Inc. lifted its stake in shares of Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after buying an additional 1,140 shares in the last quarter. True Wealth Design LLC purchased a new position in shares of Sotera Health in the third quarter worth about $32,000. Quarry LP purchased a new position in shares of Sotera Health in the fourth quarter worth about $28,000. GAMMA Investing LLC lifted its stake in shares of Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after buying an additional 1,121 shares in the last quarter. Finally, Capital Performance Advisors LLP purchased a new position in shares of Sotera Health in the third quarter worth about $91,000. 91.03% of the stock is owned by hedge funds and other institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.